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Abstract
Background: Protein tyrosine kinases are involved in signal transduction pathways that regulate
cell growth, differentiation, activation and transformation. Human lymphocyte specific kinase (Lck)
is a 56 kDa protein involved in T-cell- and IL2-receptor signaling. Three-dimensional structures are
known for SH3, SH2 and kinase domains of Lck as well as for other tyrosine kinases. No structure
is known for the unique domain of any Src-type tyrosine kinase.
Results: Lck(1–120) comprising unique and SH3 domains was structurally investigated by nuclear
magnetic resonance spectroscopy. We found the unique domain, in contrast to the SH3 part, to
have basically no defined structural elements. The solution structure of the SH3 part could be
determined with very high precision. It does not show significant differences to Lck SH3 in the
absence of the unique domain. Minor differences were observed to the X-ray structure of Lck SH3.
Conclusion: The unique domain of Lck does not contain any defined structure elements in the
absence of ligands and membranes. Presence of the unique domain is not relevant to the three-
dimensional structure of the Lck SH3 domain.
Background
Protein tyrosine kinases are involved in signal transduc-
tion pathways that regulate cell growth, differentiation,
activation and transformation. Human lymphocyte spe-
cific kinase (Lck) is a 56 kDa protein involved in T-cell-
and IL2-receptor signaling. Lck is a typical member of the
Src-type tyrosine kinase family and consists of four func-
tional domains, namely unique, SH3, SH2 and kinase.
Whereas amino acid sequences of the other domains are
highly conserved among different kinases, those of the
unique domains are not. Moreover, three-dimensional
structures are known for SH3, SH2 and kinase domains of
Lck [1–4] as well as for other tyrosine kinases. So far, how-
ever, no structure is known for the unique domain of any
Src-type kinase. Lck unique domain is thought to serve as
a membrane anchor, but also plays a role in function and
specificity of the other domains, e.g. SH2 and SH3 [5].
Further, Lck unique domain binds to the cytoplasmic re-
gions of CD4 and CD8α via cysteines and a divalent cati-
on [6,7]. Because of its key role in T cell signaling and
activation (for a review see [8]), it is not surprising that
pathogenic factors like human immunodeficiency virus
(HIV) and Herpesvirus saimiri have evolved effector mole-
cules that target Lck to ensure their own replication and
persistence. In particular, HIV-1 Nef and Herpesvirus
saimiri Tip proteins directly bind to Lck SH3 domain. HIV-
1 Nef also binds directly to CD4, which in turn binds di-
rectly to Lck unique domain. Thus, it is of interest to study
the three-dimensional structure of Lck unique und SH3
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domains as a whole, which is done in the present study by
nuclear magnetic resonance (NMR) spectroscopy.
Results
Earlier we reported almost complete assignments for 1H,
13C, and 15N resonances of human Lck unique and SH3
domains [9]. During the NOE-assignment process it be-
came obvious that unique and SH3 domains would differ
remarkably in their content of secondary structural ele-
ments and tertiary structure. While a large number of me-
dium- and long-range NOEs could be identified in the
SH3 part of the molecule (Fig. 1A), only intraresidual or
sequential NOEs were found in the unique domain. To
clarify, whether the unique part contains stable structural
elements at all, we determined heteronuclear amide NOE
values (Fig. 1B) for most of the residues in Lck(1–120). In
contrast to the unique domain, most residues of the SH3
domain show heteronuclear amide NOE values larger
than 0.6.
For the SH3 part, a total of 1817 NOE distance con-
straints, including 610 long-range NOEs (Table 1), were
derived from three-dimensional 15N or 13C edited NOESY
spectra recorded from uniformly 15N and 13C isotope la-
beled recombinantly expressed Lck(1–120) protein. These
experimental restraints were taken as input for simulated
annealing and refinement calculations. In addition, 23
residues showed 3JHNHα coupling constants either smaller
than 6.0 Hz or larger than 8.0 Hz and the respective back-
bone torsion angles were therefore restrained to adopt val-
ues between -80° to -40° or between -160° and -80°,
respectively. Together, 25 structures were obtained that
did not show any NOE distance violation greater than 0.2
Å. The root mean squared deviation of these 25 structures
relative to their average structure was 0.16 Å and 0.67 Å
for backbone and all heavy atoms, respectively. That
means, the resulting structure is rather well defined as
seen in the overlay of all 25 protein backbone and side
chain atoms (Fig. 2A). Because only residues of the SH3
part of the molecules contributed to experimental data
used for the structure calculations, the unique part is not
displayed on the figures describing the structure of Lck(1–
120).
Large average local displacement values relative to the
mean structure indicate either local flexibility of the pro-
tein or lack of experimental data for this region. Evalua-
tion of these values for Lck SH3 solution structure indicate
regions Leu69-Gly81, Gln93-Glu96, and Asn114Val116
of the protein to be less defined (Fig. 1C). The first two re-
gions have also slightly decreased heteronuclear NOE val-
ues (Fig. 1B) indicating increased dynamic behavior of the
residues therein. Those regions also show minor differ-
ences between the solution structure and the crystal struc-
ture (Fig. 2C). We deposited our data in the PDB under
accession code 1KIK.
Discussion
1H-15N-heteronuclear amide NOE values are a measure
for the dynamics of the local environment within the time
scale of the absolute nuclear magnetic resonance (NMR)
frequencies (60 to 750 MHz in the present study). While
negative 1H,15N-Hetero NOE values indicate flexible, un-
structured regions, stabilizing structural elements give rise
to values above 0.6 [10]. As can be seen from figure 1B,
residues of the unique domain show increased dynamic
behavior. In addition, while a large number of medium-
and long-range NOEs could be identified in the SH3 part
of the molecule, only intraresidual or sequential NOEs
were found for protons in the unique domain (fig. 1A).
Our data clearly show that the complete unique domain
is absent of any stable structural element. From our data,
however, this can only be inferred for the absence of
membranes or ligands. Whether the unique domain
adopts a defined tertiary structure in the presence of Lck
SH2 or kinase domains, a ligand, or when anchored in the
membrane, remains to be determined.
In contrast to the unique domain, most residues of the
SH3 domain show 1H,15N-heteronuclear amide NOE val-
ues larger than 0.6, indicating that this part of the mole-
cule contains stable structural elements. Thus, only the
SH3 part of the molecule was object to further evaluation
of structural data. Together, 25 structures were obtained
from simulated annealing molecular dynamics calcula-
tions based on experimental conformational restraint da-
ta. The obtained structures did not show any NOE
distance violation greater than 0.2 Å. The root mean
square deviation of these 25 structures relative to their av-
erage structure was 0.16 Å and 0.67 Å for backbone and all
heavy atoms, respectively. That means, the resulting struc-
ture is rather well defined as seen in the overlay of all 25
protein backbone and side chain atoms (Fig. 2A).
The solution structure of Lck SH3 is very similar to the
crystal structure of Lck SH3 [1] (Fig. 2C). It exhibits a typ-
ical SH3 fold consisting of five antiparallel β-strands (βA:
Leu65 to Ala68; βB: Gln87 to Glu92; βC: Trp92 to Ser102;
βD: Glu108 to Pro112 and βE: Val116 to Lys118, Fig. 2B),
that are forming two β-sheets packed at almost right an-
gles, with strand βB participating in both sheets. A 310-he-
lix formed by residues Phe113 to Phe115 was detected in
two of 25 structures. This may suggest that the 310-helix
frequently observed in crystal structures of SH3 domains
is not necessarily present in all of the molecules in solu-
tion. It may, however, indicate as well that this is only due
to lack of experimental data for this region (fig. 1A), lead-
ing to increased local displacement values (fig. 1B) de-
spite high heteronuclear NOE values (fig. 1C) for residuesBMC Structural Biology 2003, 3 http://www.biomedcentral.com/1472-6807/3/3
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Figure 1
Number of experimental distance constraints per residue and dynamic behavior of Lck unique and SH3 
domains, as well as local precision of SH3 domain conformation. A: Number of intraresidual (black), sequential (light 
gray), medium (dark gray) and long range (white) NOE distance constraints per residue of Lck(1–120). B: Heteronuclear 1H-
15N-NOE values of Lck(1120) amide resonances. Proline residues are indicated (P), the position of the unique and the SH3 
domains are marked with labeled horizontal bars. C: Average local displacement values among the 25 obtained solution struc-
tures of Lck(64–120). For each three-residue window the average displacement of the backbone atoms was calculated and 
plotted against the residue number that corresponds to the central residue of the window. Location of secondary structure 
elements is given at the bottom.BMC Structural Biology 2003, 3 http://www.biomedcentral.com/1472-6807/3/3
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Figure 2
Representation of Lck(64–120) structure. A: Overlay of 25 structures of Lck(64–120). Structures were fitted to back-
bone atoms of residues 64 to 120. The backbone is colored in black, side chains are colored in light gray. B: The structure of 
Lck(64–120) is shown as ribbon diagram. C: Superposition of the crystal structure (black) [1] and the solution structure (gray) 
with the lowest energy of the Lck SH3 domain.BMC Structural Biology 2003, 3 http://www.biomedcentral.com/1472-6807/3/3
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around Phe115. Another NMR study on Lck SH3 that was
published during the time course of the present study,
also did not detect such a 310-helix [4].
The root mean square deviation (rmsd) value for the back-
bone coordinates of residues Asn64 to Asn120 is 1.05 Å
between the hereby reported solution and the crystal [1]
structure. The coordinates for the very carboxyl terminal
residues, however, differ remarkably. Comparison with a
previously reported solution structure of Lck SH3 domain
[2] was not possible due to the lack of data deposition in
the Brookhaven Protein Data Bank (PDB).
Conclusions
Employing recombinant human Lck comprising its
unique and SH3 domains, we determined the solution
structure of Lck SH3 with very high precision in the pres-
ence of Lck unique domain. We report for the first time
structural aspects of a Src-type tyrosine kinase unique do-
main. In the absence of membranes or ligands, Lck
unique domain does not contain any stable structural el-
ements. Whether Lck unique domain adopts any defined
structure in the presence of membranes or interaction




Expression and purification of residues 1 to 120 of human
Lck comprising its unique and SH3 domains (LckU3) was
carried out exactly as described earlier [9,11]. Identity of
the proteins was confirmed by MALDI-TOF-MS and N-ter-
minal amino acid sequence analysis.
NMR spectroscopy
NMR samples contained 1.6 mM protein in 20 mM sodi-
um acetate, 150 mM NaCl, pH 6.5, in 90 % H2O/10 %
D2O with 10 mM 2-mercaptoethanol and 0.02 % (by
weight) sodium azide. NMR spectra were recorded at 298
K on Varian Unity INOVA spectrometers equipped with a
triple-axis pulse-field-gradient (PFG) 1H/15N/13C probe
at proton frequencies of 600 and 750 MHz. The resonance
assignment of LckU3 was previously described [9]. Struc-
tural constraints were derived from 15N-edited NOESY-
Table 1: Constraints and structural statistics for the resulting 25 NMR structures of Lck(1–120)
Number of experimental restraints:
total number of assigned NOEs 1817
intraresidual (|i-j| = 0) 635
interresidue sequential (|i-j| = 1) 357
interresidue medium range (1 < |i-j| 5) 215
long range (|i-j| > 5) 610
X-PLOR energies (kcal/mol)
total 234.7 ± 1.13
bond 17.34 ± 0.27
angle 88.15 ± 0.79
impropers 10.91 ± 0.53
Van-der-Waals 56.01 ± 0.92
NOE 62.26 ± 0.88
RMS deviations to the mean structure (Å)
backbone heavy atoms 0.16 ± 0.04
all heavy atoms 0.67 ± 0.09
RMS deviations to experimental constraints and idealized geometry
NOE (Å) 0.0212 ± 0.0001
bond (Å) 0.0031 ± 0
angle (Å) 0.4183 ± 0.0019
impropers (°) 0.2721 ± 0.0066
Φ, Ψ angles consistent with Ramachandran plot (%)
most favored regions 70.9
allowed regions 100
generously allowed regions 100BMC Structural Biology 2003, 3 http://www.biomedcentral.com/1472-6807/3/3
Page 6 of 7
(page number not for citation purposes)
HSQC (100-ms mixing time) [12] and aliphatic 13C-edit-
ed NOESY-HSQC (80-ms mixing time) experiments [13]
in the described buffer. Uniformly 13C-15N-labelled pro-
tein was used for these experiments. 15N-labelled protein
was employed for the 1H-15N-heteronuclear NOE experi-
ments [14].
Data evaluation and structure calculation
Based on the almost complete assignment of 1H, 13C, and
15N resonances of LckU3, a total of 1817 NOE distance
constraints (including 610 long-range NOEs) could be de-
rived from three-dimensional NOESY spectra in an itera-
tive procedure (Table 1). NOE analysis and assignment
was performed using XEASY [15] and ARIA [16]. Interpro-
ton distances were used directly to calibrate experimental
peaks and to extract distance constraints [16]. Lower and
upper bounds for distance constraints were derived from
the target distances empirically by estimation of the error
as 12.5% of the target distance squared. Distances involv-
ing ambiguous constraints, methyl groups, aromatic ring
protons and the non-stereospecifically assigned methyl-
ene protons were treated as sum of separate contributions
to the target function, known as "sum averaging" [17]. Fi-
nal structures were calculated using the simulated anneal-
ing protocol with CNS version 1.0 [18] using standard
parameters with the following modifications: For confor-
mational space sampling 20 ps with a time step of 10 fs
were simulated using torsion angle dynamics at a temper-
ature of 50000 K, followed by 30 ps of slow cooling to 0
K with a time step of 15 fs. In an additional Cartesian slow
cooling stage, the temperature was decreased for 20 ps
from 2000 K to 0 K with a time step of 5 fs. After simulated
annealing the structures were subjected to 2000 steps of
energy minimization. A total of 25 structures that did not
show any distance constraint violation of more than 0.2 Å
was used for further analysis. Geometry of the structures,
structural parameters and secondary structure elements
were analyzed and visualized using the programs MOL-
MOL [19] and PROCHECK [20]. The coordinates of the
SH3 domain have been deposited in the Protein Data
Bank, with accession code 1KIK.
List of abbreviations
Lck: lymphocyte specific kinase.
NMR: nuclear magnetic resonance.
Src: Src kinase.
SH2: Src homology domain 2.
SH3: Src homology domain 3.
NOE: nuclear Overhauser enhancement.
NOESY: NOE spectroscopy.
HSQC: heteronuclear single quantum coherence.
LckU3: Lck part comprising unique and SH3 domains.
MALDI-TOF-MS: Matrix-assisted laser desorption/ionisa-
tion-time of flight mass spectrometry.
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